iCAT for Recurrent/Refractory/HR Solid Tumors

NCT01853345 · clinicaltrials.gov ↗
COMPLETED
Status
101
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Dana-Farber Cancer Institute